Creatine and the menopause: why women need phosphocreatine

Searches for «creatine for women» have grown by +60% over the past year in Spain, according to Google Trends. Something has shifted and creatine and the menopause: why women need phosphocreatine is the question at the centre of it. The latest science is confirming that women not only can take creatine, but may need it more than anyone else, particularly from their forties onwards.

What the menopause does to your body (and nobody links to energy)

When oestrogen levels fall during the menopause, the body undergoes a process of change that goes well beyond hot flushes. At a muscular and cellular level, something significant takes place:

  • Muscle mass decreases progressively (sarcopenia).
  • Bone density reduces, increasing the risk of osteoporosis.
  • Cellular energy production becomes less efficient.
  • Fatigue, difficulty concentrating, and brain fog appear.

All of this is directly linked to the drop in available phosphocreatine in both muscle and brain. And here comes the key finding: women have between 70% and 80% fewer muscular phosphocreatine reserves than men, according to the International Society of Sports Nutrition (ISSN, 2025). This means their need for supplementation is, proportionally, greater.

What does phosphocreatine have to do with all this?

Conventional creatine (monohydrate) reaches the muscle and brain in an inactive form. To become usable energy, the body must convert it into phosphocreatin, a process that takes time and resources. During the menopause, that conversion process becomes even less efficient.

Clonapure already includes phosphocreatine in its formula, the active form the body uses directly. This eliminates the conversion step and allows for a faster, more efficient effect, which is especially relevant when cellular capacity is compromised by hormonal changes.

Documented benefits of creatine for women during the menopause

The scientific evidence supports the use of creatine at this stage of life. These are the benefits most consistently backed by recent research:

  • Preservation of muscle mass when combined with strength training.
  • Improved bone density and reduced risk of osteoporosis.
  • Better cognitive performance, memory, and concentration.
  • Reduction of fatigue and greater energy availability throughout the day.
  • Possible improvement in mood, particularly in contexts of chronic fatigue.

A systematic review published in Nutrition Reviews (February 2026) confirms that creatine may be associated with cognitive benefits in adults over 55, particularly in memory and attention. And Clonapure’s own muscular ATP synthesis study (American Journal of Sports Science, 2025) demonstrated that phosphocreatine raises cellular ATP levels more effectively than standard monohydrate.

Frequently asked questions

Does creatine cause water retention in women? Not in the way people fear. Creatine increases intracellular water within the muscle, which improves its performance and toned appearance. It does not cause subcutaneous bloating or visible retention.

Will it make women bulk up excessively? No. Women have significantly lower testosterone levels than men, making it physiologically very difficult to develop bulky musculature. Creatine improves strength and tone, not size.

When is the best time to take it? The recommended dose is 3 grams per day, ideally after training or with a meal. Clonapure is available in powder, softgels, and sticks, making it easy to incorporate into any routine.

The menopause is not the moment to stop looking after yourself. It is the moment to do so more intelligently. Creatine and, in particular, the already-active phosphocreatine in Clonapure, offers women a science-backed tool for maintaining muscle mass, protecting bones, supporting the mind, and restoring energy during a period of profound hormonal change.

References

Smith-Ryan AE et al. Creatine in women’s health: bridging the gap from menstruation through pregnancy to menopause. J Int Soc Sports Nutr. 2025;22(1):2502094. https://jissn.biomedcentral.com/articles/10.1186/s12970-025-00000-0

Lapena-Luzon T et al. Evaluation of the Effect of Clonapure® Versus Creatine Monohydrate on ATP Levels in a C2C12 Muscle Cell Line. Am J Sports Sci. 2025;13(2):50–56. https://article.aascit.org/file/pdf/9290979.pdf

Marshall S et al. Creatine and Cognition in Aging: A Systematic Review. Nutr Rev. 2026 Feb;84(2):333–344. https://academic.oup.com/nutritionreviews/article/84/2/333/7929254

Candow DG et al. Creatine monohydrate supplementation for older adults and clinical populations. J Int Soc Sports Nutr. 2025;22(sup1):2534130. https://jissn.biomedcentral.com/articles/10.1186/s12970-025-02534-130

Clonapure
Resumen de privacidad

Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.